TC
WST icon

TFS Capital’s West Pharmaceutical WST Stock Holding History

TFS Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,998
Closed -$529K – 1382
2014
Q1 		$529K Buy
11,998
+5,788
+93% +$272K 0.04% 705
2013
Q4 		$305K Sell
6,210
-194,570
-97% -$9.11M 0.01% 1089
2013
Q3 		$8.26M Buy
200,780
+99,192
+98% +$3.78M 0.38% 29
2013
Q2 		$3.57M Buy
+101,588
New +$3.34M 0.15% 172

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TFS Capital's WST Position: Q2 2014 in Review

TFS Capital sold out of West Pharmaceutical (WST) in Q2 2014, closing a stake of 11,998 shares — an estimated $529K sold.

TFS Capital first reported a position in WST in Q2 2013 and held it in 4 quarters. The position peaked at $8.26M in Q3 2013. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

  • TFS Capital reported no remaining West Pharmaceutical position as of Q2 2014 after selling out during the quarter.
  • TFS Capital sold 11,998 West Pharmaceutical shares in Q2 2014, an estimated $529K.
  • TFS Capital first reported a position in West Pharmaceutical in Q2 2013 and held it in 4 quarters.
  • TFS Capital's West Pharmaceutical position peaked at $8.26M in Q3 2013.
  • 222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.